Samsung Biologics Co Ltd Free Cash Flow Generation Index
Samsung Biologics Co Ltd free cash flow generation index. Samsung Biologics Co Ltd (207940) has a Free Cash Flow Generation Index of 0.84x as of June 2026. Free cash flow of ₩525.72 Billion represents 1% of operating cash flow (₩624.80 Billion).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Samsung Biologics Co Ltd (2017–2025)
Free cash flow generation index of Samsung Biologics Co Ltd from 2017 to 2025. Historical FCF Generation Index trend for Samsung Biologics Co Ltd across 8 annual periods. See financial flexibility index of Samsung Biologics Co Ltd to measure the company's free cash flow as a share of total liabilities.
Samsung Biologics Co Ltd Free Cash Flow Generation Index by Year (2017–2025)
Samsung Biologics Co Ltd free cash flow generation index by year from 2017 to 2025. Year-by-year Free Cash Flow Generation Index for Samsung Biologics Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Samsung Biologics Co Ltd.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.34x | ₩772.73 Billion | ₩2.25 Trillion | ₩1.48 Trillion | ▲ +102.5% |
| 2024 | 0.17x | ₩281.73 Billion | ₩1.66 Trillion | ₩1.38 Trillion | ▼ -49.6% |
| 2023 | 0.34x | ₩560.90 Billion | ₩1.67 Trillion | ₩1.11 Trillion | ▲ +671.1% |
| 2022 | -0.06x | ₩-56.18 Billion | ₩953.05 Billion | ₩956.84 Billion | ▼ -180.1% |
| 2021 | 0.07x | ₩33.44 Billion | ₩454.60 Billion | ₩406.25 Billion | ▼ -72.2% |
| 2020 | 0.26x | ₩53.52 Billion | ₩202.09 Billion | ₩139.66 Billion | ▲ +101.6% |
| 2019 | -16.85x | ₩-171.04 Billion | ₩10.15 Billion | ₩192.84 Billion | ▼ -610.9% |
| 2017 | -2.37x | ₩-354.99 Billion | ₩149.82 Billion | ₩494.12 Billion | — |